Ned received his A.B. from Harvard, a Ph.D. from Rockefeller University, and an M.D. from Cornell University. He completed his Internal Medicine residency and Medical Oncology Fellowship at Stanford and post-doctoral training with Dr. Irv Weissman, focusing on human T-cell development. He has had various leadership roles at Emory University including the Associate Director of Clinical Research for the Winship Cancer Institute, Director of Regenerative Engineering and Medicine, and holds the Rein Saral Professorship in Cancer Medicine. He has built an R01-funded research program in translational and clinical research in cancer immunology.
Dr. Waller is a clinician scientist entrepreneur and co-founded Cambium Oncology, a pre-clinical start-up, to develop a novel immune checkpoint drug targeting the receptor for vasoactive intestinal peptide. He chairs the Translational Immuno-Oncology (TIO) study section at the NIH.
